Contoured Diaphragm Offers Nonhormonal Contraception
By HospiMedica International staff writers Posted on 14 Jul 2015 |

Image: The Caya diaphragm (Photo courtesy of Kessel MEDintim).
A single-size, reusable diaphragm offers an improved barrier method for birth control, expanding options for women who do not want hormonal treatments.
The Caya contoured diaphragm is made of silicone—which is more durable than diaphragms made from latex—providing a shelf life of five years and a use life of up to two years. User-centered design features include a rim that contains a proprietary nylon spring that compresses during insertion and removal; grip dimples on the rim of the device offer a cue where to squeeze it for insertion, and a removal dome. As one size fits most women, there is no need for a fitting exam to determine correct diaphragm size.
The Caya diaphragm is inserted into the vagina like a tampon just before sexual intercourse. It fully covers the cervical os and is placed between the posterior vaginal vault and the space behind the pubic bone. During and after intercourse, the Caya prevents sperms from entering the uterus, but it must remain in the vagina for at least six hours. The Caya diaphragm is a product of Kessel MEDintim (Mörfelden-Walldorf, Germany), and has been approved by the US Food and Drug Administration (FDA).
“In talking with family planning providers about this single-size diaphragm over the past few months, their eyes 'light up' when they hear that a new diaphragm is coming to market and no fitting exam is required,” said Bob Patane, founder of HPSRx (Salem, VA, USA), designated marketer of the Caya in the USA. “Reducing barriers at the provider level could help bring this new method to a whole new generation of women who have not known that diaphragms are even an option.”
The Caya diaphragm was designed through a collaboration between PATH (Seattle, WA, USA), a global health nonprofit organization; CONRAD (Norfolk, VA, USA), a reproductive health product development organization operated through the Eastern Virginia Medical School (Norfolk, VA, USA); and the United States Agency for International Development (USAID, Washington DC, USA). During product development and clinical studies, it was called the SILCS diaphragm.
“Clinical studies confirm the single-size design fits most women who could wear a traditional diaphragm. In the recently published contraceptive effectiveness study, 76% of women were able to insert and correctly position the diaphragm simply using instructions,” said Gustavo Doncel, MD, PhD, scientific and executive director of CONRAD. “With coaching, 94% of women were able to insert, correctly position, and remove the diaphragm. This should make it easier to provide and use consistently.”
“This woman-initiated, nonhormonal contraceptive barrier method has great potential to improve women’s reproductive health options by addressing several of the reasons for unmet contraceptive need,” said Judy Manning, team lead for contraceptive research and development at USAID. “The device may fill another needed role by serving as a delivery method for gels that help protect against HIV and other sexually transmitted infections. It could be our first true multipurpose prevention product.”
Related Links:
Kessel MEDintim
HPSRx
PATH
The Caya contoured diaphragm is made of silicone—which is more durable than diaphragms made from latex—providing a shelf life of five years and a use life of up to two years. User-centered design features include a rim that contains a proprietary nylon spring that compresses during insertion and removal; grip dimples on the rim of the device offer a cue where to squeeze it for insertion, and a removal dome. As one size fits most women, there is no need for a fitting exam to determine correct diaphragm size.
The Caya diaphragm is inserted into the vagina like a tampon just before sexual intercourse. It fully covers the cervical os and is placed between the posterior vaginal vault and the space behind the pubic bone. During and after intercourse, the Caya prevents sperms from entering the uterus, but it must remain in the vagina for at least six hours. The Caya diaphragm is a product of Kessel MEDintim (Mörfelden-Walldorf, Germany), and has been approved by the US Food and Drug Administration (FDA).
“In talking with family planning providers about this single-size diaphragm over the past few months, their eyes 'light up' when they hear that a new diaphragm is coming to market and no fitting exam is required,” said Bob Patane, founder of HPSRx (Salem, VA, USA), designated marketer of the Caya in the USA. “Reducing barriers at the provider level could help bring this new method to a whole new generation of women who have not known that diaphragms are even an option.”
The Caya diaphragm was designed through a collaboration between PATH (Seattle, WA, USA), a global health nonprofit organization; CONRAD (Norfolk, VA, USA), a reproductive health product development organization operated through the Eastern Virginia Medical School (Norfolk, VA, USA); and the United States Agency for International Development (USAID, Washington DC, USA). During product development and clinical studies, it was called the SILCS diaphragm.
“Clinical studies confirm the single-size design fits most women who could wear a traditional diaphragm. In the recently published contraceptive effectiveness study, 76% of women were able to insert and correctly position the diaphragm simply using instructions,” said Gustavo Doncel, MD, PhD, scientific and executive director of CONRAD. “With coaching, 94% of women were able to insert, correctly position, and remove the diaphragm. This should make it easier to provide and use consistently.”
“This woman-initiated, nonhormonal contraceptive barrier method has great potential to improve women’s reproductive health options by addressing several of the reasons for unmet contraceptive need,” said Judy Manning, team lead for contraceptive research and development at USAID. “The device may fill another needed role by serving as a delivery method for gels that help protect against HIV and other sexually transmitted infections. It could be our first true multipurpose prevention product.”
Related Links:
Kessel MEDintim
HPSRx
PATH
Latest Patient Care News
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
- Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases
- Wearable Cardioverter Defibrillator System Protects Patients at Risk of Sudden Cardiac Arrest
Channels
Critical Care
view channel
Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more
Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
Multiphoton microscopy has become an invaluable tool in neuroscience, allowing researchers to observe brain activity in real time with high-resolution imaging. A crucial aspect of many multiphoton microscopy... Read more
Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
Until now, administering cell therapies to patients on extracorporeal membrane oxygenation (ECMO)—a life-support system typically used for severe lung failure—has been nearly impossible.... Read moreSurgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more